Results 181 to 190 of about 382,305 (392)

Autoantibody response towards chromatin in patients with juvenile idiopathic arthritis

open access: yesArthritis &Rheumatology, Accepted Article.
Objective Juvenile idiopathic arthritis (JIA) patients frequently exhibit antinuclear antibodies (ANAs), but the specific antigen target recognized by them and the presence of additional autoantibody specificities in JIA patients remains elusive. Methods Plasma samples from 110 untreated patients with active JIA, as well as from 14 children with ...
Viola Pitkänen   +13 more
wiley   +1 more source

Parathyroid Tumor Suppressor on 1p: Analysis of the p18 Cyclin-Dependent Kinase Inhibitor Gene As a Candidate [PDF]

open access: bronze, 1997
Hideki Tahara   +5 more
openalex   +1 more source

The Cyclin-dependent Kinase Family

open access: yesCold Spring Harbor Symposia on Quantitative Biology, 1991
B Faha   +4 more
openaire   +2 more sources

Approaches to repurposing reverse transcriptase antivirals in cancer

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
This review highlights the role of reverse transcriptase (RT) inhibition in cellular regulation associated with non‐terminal repeat retrotransposons and endogenous retroviruses. Based on their pleiotropic characteristics, RT inhibitors (RTIs) are discussed as potential anticancer agents.
Richard Head   +2 more
wiley   +1 more source

Inhibition of Cyclin-Dependent Kinases 8/19 Restricts Bacterial and Virus-Induced Inflammatory Responses in Monocytes. [PDF]

open access: yesViruses, 2023
Kokinos EK   +11 more
europepmc   +1 more source

Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells.

open access: green, 1994
Hiroaki Kiyokawa   +3 more
openalex   +1 more source

Identification of Substrate Binding Site of Cyclin-dependent Kinase 5 [PDF]

open access: hybrid, 1999
Pushkar Sharma   +5 more
openalex   +1 more source

Real‐world treatment patterns among patients diagnosed with hormone receptor‐positive metastatic breast cancer in the USA

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Clinical guidelines for breast cancer management have evolved in the past decade. However, limited evidence exists regarding uptake of novel drug classes in management of hormone receptor‐positive (HR+) metastatic breast cancer (MBC) in the USA and whether disparities exist by race and ethnicity.
Kexin Zhu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy